CLCNKA and familial dilated cardiomyopathy: In our prior genetic analysis of the UK Biobank, we refined a heterogeneous heart failure phenotype to a specific, nonischemic cardiomyopathy subset, enabling detection of two DCM risk loci (near BAG3 and CLCNKA) that associated with subclinical changes in LV structure and function32.